Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 380

1.

Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin.

Alzoubi KH, Al-Ibbini AM, Nuseir KQ.

Psychiatry Res. 2018 Oct 6;270:430-437. doi: 10.1016/j.psychres.2018.10.008. [Epub ahead of print]

PMID:
30316170
2.

[Comorbid cognitive impairments in children with nocturnal enuresis and their treatment].

Chutko LS, Surushkina SY, Yakovenko EA, Anisimova TI, Volov MB, Rozhkova AV, Sergeev AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(5. Vyp. 2):57-63. doi: 10.17116/jnevro20181185257. Russian.

PMID:
30141789
3.

Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity in photothrombotic mouse model of medial prefrontal cortex ischemia.

Sadigh-Eteghad S, Geranmayeh MH, Majdi A, Salehpour F, Mahmoudi J, Farhoudi M.

Neuropeptides. 2018 Oct;71:61-69. doi: 10.1016/j.npep.2018.07.002. Epub 2018 Jul 10.

PMID:
30054019
4.

Cerebrolysin: a multi-target drug for recovery after stroke.

Brainin M.

Expert Rev Neurother. 2018 Aug;18(8):681-687. doi: 10.1080/14737175.2018.1500459. Epub 2018 Jul 18.

PMID:
30004268
5.

[Anti-inflammatory effects of neurotrophic therapy (a pilot study)].

Malashenkova IK, Krynskiy SA, Hailov NA, Ogurtsov DP, Selezneva ND, Fedorova YB, Ponomareva EV, Kolyhalov IV, Gavrilova SI, Didkovsky NA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(5):39-44. doi: 10.17116/jnevro20181185139. Russian.

PMID:
29927402
6.

Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats.

Mahmoudi J, Mohaddes G, Erfani M, Sadigh-Eteghad S, Karimi P, Rajabi M, Reyhani-Rad S, Farajdokht F.

Brain Res Bull. 2018 Jun;140:197-204. doi: 10.1016/j.brainresbull.2018.05.008. Epub 2018 May 9.

PMID:
29752991
7.

Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic Stroke.

Catalin B, Rogoveanu OC, Pirici I, Balseanu TA, Stan A, Tudorica V, Balea M, Mindrila I, Albu CV, Mohamed G, Pirici D, Muresanu DF.

CNS Neurol Disord Drug Targets. 2018;17(4):299-308. doi: 10.2174/1871527317666180425124340.

PMID:
29692268
8.

Effectiveness of arginase inhibitors against experimentally induced stroke.

Barakat W, Fahmy A, Askar M, El-Kannishy S.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Jun;391(6):603-612. doi: 10.1007/s00210-018-1489-1. Epub 2018 Mar 29.

PMID:
29600431
9.

[The efficacy of prevention of postoperative cognitive dysfunction in cardiac surgeries with the use of the cerebrolysin].

Polushin AY, Yanishevskiy SN, Maslevtsov DV, Krivov VO, Beskrovnaya OV, Molchan NS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12):37-45. doi: 10.17116/jnevro201711712137-45. Russian.

PMID:
29376982
11.

Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.

Zhang Y, Chopp M, Gang Zhang Z, Zhang Y, Zhang L, Lu M, Zhang T, Winter S, Brandstätter H, Mahmood A, Xiong Y.

J Neurosurg. 2018 Jan 5:1-10. doi: 10.3171/2017.6.JNS171007. [Epub ahead of print]

PMID:
29303438
12.

Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.

Bornstein NM, Guekht A, Vester J, Heiss WD, Gusev E, Hömberg V, Rahlfs VW, Bajenaru O, Popescu BO, Muresanu D.

Neurol Sci. 2018 Apr;39(4):629-640. doi: 10.1007/s10072-017-3214-0. Epub 2017 Dec 16.

13.

Synthesis of Biocompatible Titanate Nanofibers for Effective Delivery of Neuroprotective Agents.

Ozkizilcik A, Williams R, Tian ZR, Muresanu DF, Sharma A, Sharma HS.

Methods Mol Biol. 2018;1727:433-442. doi: 10.1007/978-1-4939-7571-6_35.

PMID:
29222803
14.

[Staging of neuroplasticity alterations during epileptogenesis (temporal lobe epileply as an example)].

Gulyaeva NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(9. Vyp. 2):10-16. doi: 10.17116/jnevro20171179210-16. Russian.

PMID:
29213032
15.

Effects of cerebrolysin on nerve growth factor system in the aging rat brain.

Stepanichev M, Onufriev M, Aniol V, Freiman S, Brandstaetter H, Winter S, Lazareva N, Guekht A, Gulyaeva N.

Restor Neurol Neurosci. 2017;35(6):571-581. doi: 10.3233/RNN-170724.

16.

[Monitoring of neurotrophic factors and cognitive function in patients with traumatic brain injury].

Karakulova YV, Selyanina NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):34-37. doi: 10.17116/jnevro201711710134-37. Russian.

PMID:
29171486
17.

Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study.

Allam AFA, Abotakia TAA, Koptan W.

Spine J. 2018 Jul;18(7):1136-1142. doi: 10.1016/j.spinee.2017.11.002. Epub 2017 Nov 14.

PMID:
29155000
18.

Clinical effects of Ganglioside and fructose-1, 6-diphosphate on neonatal heart and brain injuries after Asphyxia.

Zhu X, Li H, Zhang C.

Pak J Med Sci. 2017 Sep-Oct;33(5):1199-1204. doi: 10.12669/pjms.335.12830.

19.

Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment.

Menon PK, Sharma A, Lafuente JV, Muresanu DF, Aguilar ZP, Wang YA, Patnaik R, Mössler H, Sharma HS.

Int Rev Neurobiol. 2017;137:47-63. doi: 10.1016/bs.irn.2017.08.005. Epub 2017 Nov 3. Review.

PMID:
29132543
20.

Novel Treatment Strategies Using TiO2-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease.

Sharma A, Menon PK, Patnaik R, Muresanu DF, Lafuente JV, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma HS.

Int Rev Neurobiol. 2017;137:123-165. doi: 10.1016/bs.irn.2017.09.002. Epub 2017 Nov 6. Review.

PMID:
29132541

Supplemental Content

Loading ...
Support Center